by Chris Thurstone | Mar 18, 2016 | Marijuana, Research
The news from London-based GW Pharmaceuticals is worth celebrating: Epidiolex — purified, pharmacy-grade and nonintoxicating cannabidiol extracted from the cannabis plant — has both Orphan Drug Designation and Fast Track Designation from the U.S. Food and...
by Chris Thurstone | Feb 3, 2015 | Marijuana, Public Policy, Uncategorized
In May 2013, I observed spiking THC levels in my young patients and a rapidly growing market in Colorado for foods and drinks infused with the drug, the active ingredient of marijuana that produces a euphoric high. What I saw prompted me to raise concerns about what...
by Chris Thurstone | Jun 26, 2014 | Public Policy, Research, Uncategorized
First, please let me be clear: I want more research of Cannabidiol, the nonintoxicating component of the cannabis plant that has shown some medical promise — particularly for the treatment of children with intractable epilepsy. I want that research to comply...
by Chris Thurstone | May 9, 2013 | Research
In the last several months, my colleagues and I have noticed rising levels of THC in the urine of our young patients — but the average increase I present here surprised even us. THC, which is short for tetrahydrocannabinol, is the active ingredient in marijuana...